Asparkam-Ubf

Asparkam-UBF: description, application and side effects

Asparkam-UBF is a drug that regulates water and electrolyte balance in the body. It is produced by Uralbiopharm in Russia. The main active ingredient is potassium and magnesium aspartate, the international name of which is also used in the name of the drug.

Indications for the use of Asparkam-UBF include arrhythmias caused by hypokalemia, as well as ventricular extrasystole and circulatory failure. The drug can also be used to correct hypokalemia when using loop diuretics and intoxication with cardiac glycosides.

However, the use of Asparkam-UBF has a number of contraindications and limitations. For example, it cannot be used for renal failure, hyperkalemia and II-III degree AV block. The drug may also cause side effects such as nausea, dizziness, diarrhea, intraventricular conduction disturbances, facial flushing, thirst, decreased blood pressure, hyporeflexia, respiratory depression, impaired neuromuscular transmission and arrhythmias.

In addition, the interaction of Asparkam-UBF with other medications can also lead to undesirable effects. For example, it may reduce the effectiveness of cardiac glycosides, and potassium-sparing diuretics and ACE inhibitors may increase the risk of hyperkalemia.

In case of an overdose of the drug, conduction disturbances may occur, especially in the presence of previous pathology of the conduction system. Therefore, it is especially important to follow the dosage and contraindications specified in the instructions for the drug.

In conclusion, Asparkam-UBF is a drug that can help regulate water and electrolyte balance in the body. However, its use may have contraindications and cause side effects, so you should consult a specialist before using it.